Mbx Biosciences, Inc To Start Trading Tomorrow
Mbx Biosciences, Inc To Start Trading Tomorrow
MBX Biosciences, Inc (NASDAQ:MBX) IPO will take place September, 13 on the NASDAQ exchange under the ticker MBX.
MBX Biosciences, Inc（纳斯达克股票代码：MBX）的首次公开募股将于9月13日在纳斯达克交易所进行，股票代码为MBX。
The company is offering shares at an expected price between $14.00 and $16.00 per share with an insider lock-up period of 180 days ending on March 12, 2025.
该公司发行股票的预期价格在每股14.00美元至16.00美元之间，内部封锁期为180天，将于2025年3月12日结束。
See also: Benzinga IPO Calendar
另见：Benzinga IPO 日历
About MBX Biosciences, Inc
关于 MBX 生物科学公司
MBX Biosciences, Inc is a clinical-stage biopharmaceutical company focused on the discovery and development of novel precision peptide therapies for the treatment of endocrine and metabolic disorders.
MBX Biosciences, Inc是一家处于临床阶段的生物制药公司，专注于发现和开发用于治疗内分泌和代谢疾病的新型精准肽疗法。
See also: Benzinga's Most Shorted Stocks
另见：本辛加最常做空的股票
This article was generated by Benzinga's automated content engine and reviewed by an editor.
本文由Benzinga的自动内容引擎生成，并由编辑审阅。